FMT
SNDX icon

First Mercantile Trust’s Syndax Pharmaceuticals SNDX Stock Holding History

First Mercantile Trust’s Portfolio SNDX Stock Details SNDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$66K Sell
3,433
-192
-5% -$3.2K 0.01% 742
2021
Q2 		$62K Sell
3,625
-312
-8% -$5.71K 0.01% 775
2021
Q1 		$88K Buy
3,937
+1,946
+98% +$44K 0.01% 709
2020
Q4 		$44K Buy
+1,991
New +$41.3K 0.01% 792

Other funds holding SNDX

APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

First Mercantile Trust's SNDX Position: Q3 2021 in Review

First Mercantile Trust reduced its Syndax Pharmaceuticals (SNDX) stake by 5.3% in Q3 2021, selling an estimated $3.2K and leaving 3,433 shares worth $66K. The position accounts for 0.01% of the portfolio, ranked #742.

First Mercantile Trust first reported a position in SNDX in Q4 2020 and has held it in 4 quarters since. The position peaked at $88K in Q1 2021. 123 funds tracked by Wall St. Rank hold SNDX as of Q3 2021.

  • First Mercantile Trust held 3,433 shares of Syndax Pharmaceuticals worth $66K as of Q3 2021.
  • First Mercantile Trust sold 192 Syndax Pharmaceuticals shares in Q3 2021, an estimated $3.2K.
  • Syndax Pharmaceuticals made up 0.01% of First Mercantile Trust's portfolio in Q3 2021, its #742 holding.
  • First Mercantile Trust first reported a position in Syndax Pharmaceuticals in Q4 2020 and has held it in 4 quarters since.
  • First Mercantile Trust's Syndax Pharmaceuticals position peaked at $88K in Q1 2021.
  • 123 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q3 2021.

Based on First Mercantile Trust's 13F filing for Q3 2021, filed 24 Nov 2021.